October 6, 2023
984
21
7
2.85%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
5:16Now PlayingSales of the weight loss drugs Ozempic and Wegovy are booming, driving massive profits for their Danish manufacturer Novo Nordisk. As demand grows, the race is on to develop similar drugs, impacting not only lifestyle but business, too. Walmart's U.S. CEO is already noting declining grocery sales among users.
This trend is likely to continue, with up to 24 million people (almost 7% of the U.S. population) expected to use these drugs in the next decade. Joining "Elizabeth Vargas Reports" is business contributor Lydia Moynihan who shares how these drugs are changing food consumption habits.
#Weightloss #Wegovy #Ozempic #Walmart
Anchor Elizabeth Vargas delivers the biggest stories, without bias or opinion. Watch "Elizabeth Vargas Reports" every weeknight at 6p/5C on NewsNation. #VargasReports
NewsNation is your source for fact-based, unbiased news for all America.
More from NewsNation
Get our app
Find us on cable
How to watch on TV or streaming
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.